Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity

Alexander M M Eggermont, Stefan Suciu, Piotr Rutkowski, Willem H. Kruit, Cornelis J. Punt, Reinhard Dummer, François Salès, Ulrich Keilholz, Gaetan De Schaetzen, Alessandro Testori

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity'. Together they form a unique fingerprint.

Medicine & Life Sciences